A potential explanation of this discrepancy could be lower glucocorticoid sensitivity of melanoma cells and a correspondingly slower melanoma progression in individuals with GR polymorphisms conferring glucocorticoid resistance and lower VAT accumulation [46]. The gene discussed is NR3C1; the disease is melanoma.